{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:02:10Z","timestamp":1794085330265,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2018-0339"],"award-info":[{"award-number":["2018-0339"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["20\/12"],"award-info":[{"award-number":["20\/12"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["17\/07_1FCR"],"award-info":[{"award-number":["17\/07_1FCR"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["17593"],"award-info":[{"award-number":["17593"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG2017"],"award-info":[{"award-number":["IG2017"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["TRANSCALL-2 (ID 189"],"award-info":[{"award-number":["TRANSCALL-2 (ID 189"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20564"],"award-info":[{"award-number":["20564"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007479","name":"Fondazione Cariparo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001942","name":"European Coordinated Research on Long-term Challenges in Information and Communication Sciences & Technologies ERA-NET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02364753"],"award-info":[{"award-number":["GR-2016-02364753"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ebiom.2022.104224","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T18:37:37Z","timestamp":1660675057000},"page":"104224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8422","authenticated-orcid":false,"given":"Grazia","family":"Fazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-7774","authenticated-orcid":false,"given":"Claudia","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Buldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-1012","authenticated-orcid":false,"given":"Chiara","family":"Palmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Savino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Peloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wey","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-7744","authenticated-orcid":false,"given":"Sanil","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-1431","authenticated-orcid":false,"given":"Concetta","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lo Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Conter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-4795","authenticated-orcid":false,"given":"Geertruij","family":"te Kronnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2022.104224_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104224_bib0002","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104224_bib0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clml.2017.03.299","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"17","author":"Pui","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104224_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062193","article-title":"The current genomic and molecular landscape of Philadelphia-like acute lymphoblastic leukemia","volume":"21","author":"Shiraz","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.ebiom.2022.104224_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104224_bib0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOH.0000000000000050","article-title":"Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises","volume":"21","author":"Izraeli","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104224_bib0007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104224_bib0008","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3324\/haematol.2019.231720","article-title":"Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols","volume":"105","author":"Cario","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104224_bib0009","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1(plus) defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104224_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ni1454","article-title":"Pax5: the guardian of B cell identity and function","volume":"8","author":"Cobaleda","year":"2007","journal-title":"Nat Immunol"},{"issue":"7137","key":"10.1016\/j.ebiom.2022.104224_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104224_bib0012","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104224_bib0013","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/gcc.22882","article-title":"Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol","volume":"59","author":"ung","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104224_bib0014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/leu.2012.281","article-title":"PAX5\/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5","volume":"27","author":"Fazio","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104224_bib0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.18632\/oncotarget.2807","article-title":"LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients","volume":"6","author":"Cazzaniga","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104224_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2006.01.012","article-title":"Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells","volume":"24","author":"Delogu","year":"2006","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104224_bib0017","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104224_bib0018","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40265-015-0418-6","article-title":"Nintedanib: a review of its use in patients with idiopathic pulmonary fibrosis","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ebiom.2022.104224_bib0019","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2147\/OTT.S78805","article-title":"Profile of nintedanib in the treatment of solid tumors: the evidence to date","volume":"8","author":"Awasthi","year":"2015","journal-title":"Onco Targets Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104224_bib0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of nintedanib","volume":"58","author":"Wind","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"16","key":"10.1016\/j.ebiom.2022.104224_bib0021","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.ebiom.2022.104224_bib0022","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7708","key":"10.1016\/j.ebiom.2022.104224_bib0023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-018-0177-0","article-title":"Hippo\/Mst signalling couples metabolic state and immune function of CD8alpha(+) dendritic cells","volume":"558","author":"Du","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104224_bib0024","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/bioinformatics\/bty907","article-title":"SJARACNe: a scalable software tool for gene network reverse engineering from big data","volume":"35","author":"Khatamian","year":"2019","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104224_bib0025","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.3324\/haematol.2013.099077","volume":"98","author":"Palmi","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104224_bib0026","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1097\/HS9.0000000000000250","article-title":"A simple RNA target capture NGS Strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia","volume":"3","author":"Grioni","year":"2019","journal-title":"Hemasphere"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104224_bib0027","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/2159-8290.CD-13-0350","article-title":"Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia","volume":"3","author":"Pemovska","year":"2013","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104224_bib0028","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2017-10-810986","article-title":"Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response","volume":"132","author":"Bhatia","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104224_bib0029","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI93801","article-title":"Drug-perturbation-based stratification of blood cancer","volume":"128","author":"Dietrich","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104224_bib0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2643-3230.BCD-19-0059","article-title":"An Autochthonous mouse model of Myd88- and BCL2-driven diffuse large B-cell lymphoma reveals actionable molecular vulnerabilities","volume":"2","author":"Flumann","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.ebiom.2022.104224_bib0031","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies","volume":"4","author":"Yadav","year":"2014","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104224_bib0032","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104224_bib0033","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.chembiol.2010.09.010","article-title":"Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry","volume":"17","author":"Wodicka","year":"2010","journal-title":"Chem Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104224_bib0034","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-12-0415-T","article-title":"LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells","volume":"11","author":"Talab","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104224_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejca.2017.06.012","article-title":"BCR-ABL1-like acute lymphoblastic leukaemia: from bench to bedside","volume":"82","author":"Boer","year":"2017","journal-title":"Eur J Cancer"},{"issue":"10299","key":"10.1016\/j.ebiom.2022.104224_bib0036","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(21)01289-7","article-title":"CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia","volume":"398","author":"Maus","year":"2021","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ebiom.2022.104224_bib0037","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood.2020009032","article-title":"Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants","volume":"137","author":"Fazio","year":"2021","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.ebiom.2022.104224_bib0038","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1182\/blood-2017-05-784603","article-title":"Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia","volume":"130","author":"Serafin","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104224_bib0039","first-page":"1056","article-title":"Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia","volume":"106","author":"Shi","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104224_bib0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/09168451.2018.1549974","article-title":"AKT phosphorylation sites of Ser473 and Thr308 regulate AKT degradation","volume":"83","author":"Wei","year":"2019","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:43Z","timestamp":1778873683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S2352396422004066"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104224","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104224"}}